I now have comprehensive information from multiple textbooks with excellent pathway diagrams. Here's a complete synthesis:
Creatine Biosynthesis Pathway
Creatine synthesis is a two-step, two-organ process using three amino acid precursors: glycine, arginine, and methionine (as SAM).
Step 1 — Guanidinoacetate formation (Kidneys)
Arginine + Glycine → Guanidinoacetate + Ornithine
Enzyme: Arginine:glycine amidinotransferase (AGAT)
The amidino group (–C(=NH)–NH₂) is transferred from arginine to glycine, producing guanidinoacetate (glycocyamine). Ornithine is released as a byproduct and re-enters the urea cycle. This step occurs primarily in the kidney (and to a lesser extent the pancreas).
Step 2 — Methylation to creatine (Liver)
Guanidinoacetate + SAM → Creatine + S-adenosylhomocysteine
Enzyme: Guanidinoacetate methyltransferase (GAMT)
SAM (S-adenosylmethionine), derived from methionine, donates its methyl group to guanidinoacetate. This reaction occurs in the liver. Creatine is then released into the circulation.
This methylation step consumes ~40% of all SAM-derived methyl groups in the body — making creatine synthesis the single largest consumer of methyl groups in human metabolism.
Pathway Diagram (Harper's Biochemistry)
FIGURE 30-12: Biosynthesis of creatine and creatinine — Harper's Illustrated Biochemistry, 32nd Ed.
Downstream: Phosphocreatine & Creatinine
| Step | Reaction | Enzyme/Process |
|---|
| Transport | Creatine → muscle/brain via bloodstream | Creatine transporter SLC6A8 (Na⁺/Cl⁻-dependent) |
| Phosphorylation | Creatine + ATP → Creatine phosphate + ADP | Creatine kinase (CK) |
| Degradation | Creatine phosphate → Creatinine + Pᵢ | Nonenzymatic, irreversible, in muscle |
Creatinine is excreted in urine at a rate proportional to total muscle mass (~1–2 g/day in adult males), making it a clinical marker for muscle mass and renal clearance.
Organ Compartmentalization
Fig. 91.11: AGAT (kidney) → guanidinoacetate → GAMT (liver) → creatine → SLC6A8 transporter → muscle/brain → CK → phosphocreatine — Bradley & Daroff's Neurology in Clinical Practice
| Organ | Role |
|---|
| Kidney | AGAT reaction (Step 1) |
| Liver | GAMT reaction (Step 2) |
| Muscle/Brain | Uptake via SLC6A8, phosphorylation by CK, energy buffering |
Clinical Relevance: Creatine Deficiency Syndromes
Defects in either synthetic enzyme or the transporter cause primary creatine deficiency, presenting with:
- Intellectual disability and speech/language delay
- Autistic behavior
- Epilepsy
- Hypotonia
| Defect | GAA level | Treatment |
|---|
| AGAT deficiency | ↓ GAA | Oral creatine supplementation |
| GAMT deficiency | ↑ GAA | Oral creatine supplementation |
| SLC6A8 deficiency (transporter) | Normal GAA | Poor response to supplementation |
MRS (proton magnetic resonance spectroscopy) reveals absent or markedly reduced creatine/phosphocreatine peak in all three.
Sources: Harper's Illustrated Biochemistry, 32nd Ed., p. 323 | Lippincott's Biochemistry, 8th Ed., p. 812–813 | Bradley & Daroff's Neurology in Clinical Practice, p. 1958–1959